FDA Roundup: April 26, 2024
On Thursday, the FDA announced it has approved the first generic pimobendan for the management of congestive heart failure in dogs.
- On Thursday, the FDA announced it has approved the first generic pimobendan for the management of congestive heart failure in dogs.
- The FDA expects this firm to fully address the violations described in the warning letter.
- This represents the first FDA approval of a radioactive drug, or radiopharmaceutical, for pediatric patients 12 years of age and older with SSTR-positive GEP-NETs.
- This represents the first FDA approval of a systemic therapy for the treatment of patients with pediatric LGG with BRAF rearrangements, including fusions.